Agnes Bernet
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer.
Journal: Nature
Published: October 20, 2025
Targeting netrin-1 to inhibit epithelial-mesenchymal transition: a new insight for cancer therapy
Journal: Medecine sciences : M/S
Published: February 27, 2024
Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retinoid, and ELF3 signaling.
Journal: Cell reports
Published: January 03, 2023
Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.
Journal: Nature
Published: April 22, 2022
Pharmacological targeting of netrin-1 inhibits EMT in cancer.
Journal: Nature
Published: April 04, 2022
BSA-PEI Nanoparticle Mediated Efficient Delivery of CRISPR/Cas9 into MDA-MB-231 Cells.
Journal: Molecular biotechnology
Published: February 26, 2022
Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor.
Journal: Cell death and differentiation
Published: September 06, 2021
Dependence receptors: new targets for cancer therapy.
Journal: EMBO molecular medicine
Published: April 30, 2021
Cancer-Associated Fibroblasts Produce Netrin-1 to Control Cancer Cell Plasticity.
Journal: Cancer research
Published: September 19, 2018
Floor-plate-derived netrin-1 is dispensable for commissural axon guidance.
Journal: Nature
Published: October 20, 2016
Last Updated: 09/26/2026